Status:
COMPLETED
Electronic Clinical Decision Support for Diabetes and Dysglycaemia in Secondary Mental Healthcare
Lead Sponsor:
King's College London
Collaborating Sponsors:
National Institute for Health Research, United Kingdom
South London and Maudsley NHS Foundation Trust
Conditions:
Severe Mental Disorder
Diabetes Mellitus
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
People with serious mental illness (SMI) such as schizophrenia, schizoaffective disorder and bipolar affective disorder have a significantly reduced life expectancy, caused in part by increased incide...
Detailed Description
People with serious mental illness (SMI) such as schizophrenia, schizoaffective disorder and bipolar affective disorder have a significantly reduced life expectancy in comparison to the general popula...
Eligibility Criteria
Inclusion
- General adult psychiatry inpatient wards at South London and Maudsley NHS Foundation Trust. Wards will be entered into the study if their respective management are agreeable to participate.
- All clinical staff on recruited wards will be eligible to participate and will be invited to take part in a preliminary survey and individual interview with the research team at the start of the study.
- Staff on intervention wards will also be asked to complete a survey and individual interview at the end of the study.
Exclusion
- Staff on recruited wards who are not of a clinical or healthcare professional background.
- Staff who lack capacity to provide informed consent to participate.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT04792268
Start Date
May 1 2022
End Date
December 1 2023
Last Update
March 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South London and Maudsley NHS Foundation Trust
London, United Kingdom